Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Thrombophilia Market From 2025 to 2029?

The size of the thrombophilia market has witnessed significant growth in recent years. The market size is projected to rise from $17.03 billion in 2024 to $18.18 billion in 2025, expanding at a compound annual growth rate (CAGR) of 6.7%. The substantial growth in the historic period is a result of increasing awareness, advancements in anticoagulant therapies research and development, an aging demographic, genetic research, and a surge in thrombotic disorders incidence.

In the coming years, significant expansion is anticipated in the thrombophilia market, with projections estimating its worth at “$24.57 billion in 2029”, growing at a compound annual growth rate (CAGR) of 7.8%. The predicted surge over the forecast period can be linked to factors such as personalized medicine, the introduction of innovative therapies, the incorporation of artificial intelligence, healthcare rules and regulations, and improved patient awareness and empowerment. Key future trends comprise of technological progression, broader use of telemedicine, escalating prevalence rates, advancements in biopharmaceuticals, and combined research efforts.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9439&type=smp

What Elements Are Contributing To Growth In The Thrombophilia Market?

The continued growth of the thrombophilia market is anticipated to be spurred on by a rising elderly population. This refers to individuals who are 65 years and above, a demographic often seen as dependent due to their age, with their total numbers calculated as a proportion of the entire population. Elderly adults frequently exhibit factors that put them at risk of thrombophilia, allowing for the targeting of a demographic at risk for poor health outcomes. This consequently results in a surge in demand for thrombophilia drugs, thus driving the market. As an illustration, America’s Health Rankings, a U.S. organization focusing on health outcomes, declared that in 2022, over 56 million adults over the age of 65 comprised about 16.9% of the total U.S. population, and this number is projected to increase to over 73.1 million by 2030. Consequently, the swelling elderly population’s numbers are key in the expansion of the thrombophilia market.

Which Segments Are Detailed In The Global Thrombophilia Market Report?

The thrombophilia market covered in this report is segmented –

1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type

2) By Drugs: Heparin, Warfarin, Other Drugs

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy

2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy

3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy

4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions

How Are Key Trends Driving Expansion In The Thrombophilia Industry?

The predominant trend capturing attention in the thrombophilia market is technological innovation. Major firms are devising groundbreaking technologies to maintain their competitiveness. For instance, researchers from the University of California, San Diego, introduced a game-changing technology named Eloctate in May 2023. This revolutionary technique employs a unique fusion protein that remarkably extends the stability and half-life of coagulation factors in the bloodstream. By integrating this novel technology with currently available treatment methods, these researchers aim to develop long-lasting drugs that necessitate less regular dosing, hence enhancing patient adherence and life quality.

Who Are The Key Contributors To Growth In The Thrombophilia Market?

Major companies operating in the thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

Which Region Is Projected To Lead The Thrombophilia Market By 2025?

North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9439&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model